• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Zymeworks Inc.

< Previous 1 2 3 4 5 Next >
News headline image
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
July 22, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
July 11, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
June 17, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
June 10, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
May 28, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
April 30, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 11, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
April 08, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
March 28, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
March 27, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
March 05, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
February 27, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
February 14, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
February 08, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
January 31, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
January 04, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Additional Leadership Appointments
January 04, 2024
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
December 26, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Added to Nasdaq Biotechnology Index
December 15, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers NBI ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conference
November 30, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 07, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
November 01, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks To Host Third Quarter 2023 Results Conference Call
October 17, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces New Director Nominee
October 16, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 10, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conferences
August 01, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks To Host Second Quarter 2023 Results Conference Call
July 19, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
News headline image
Zymeworks Announces Participation in Upcoming Investor Conference
July 03, 2023
From Zymeworks Inc.
Via GlobeNewswire
Tickers ZYME
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap